These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2643818)

  • 21. The significance of subendothelial von Willebrand factor.
    Rand JH; Glanville RW; Wu XX; Ross JM; Zangari M; Gordon RE; Schwartz E; Potter BJ
    Thromb Haemost; 1997 Jul; 78(1):445-50. PubMed ID: 9198194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand factor storage requires intact prosequence cleavage site.
    Journet AM; Saffaripour S; Cramer EM; Tenza D; Wagner DD
    Eur J Cell Biol; 1993 Feb; 60(1):31-41. PubMed ID: 8462598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA.
    Bahnak BR; Wu QY; Coulombel L; Assouline Z; Kerbiriou-Nabias D; Piétu G; Drouet L; Caen JP; Meyer D
    J Cell Physiol; 1989 Feb; 138(2):305-10. PubMed ID: 2783933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism and classification of von Willebrand disease.
    Sadler JE; Matsushita T; Dong Z; Tuley EA; Westfield LA
    Thromb Haemost; 1995 Jul; 74(1):161-6. PubMed ID: 8578450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2B or not 2B? What is the role of VWF in platelet-matrix interactions? And what is the role of the VWF:CB in VWD diagnostics? These are the questions.
    Favaloro EJ
    J Thromb Haemost; 2006 Apr; 4(4):892-4. PubMed ID: 16634760
    [No Abstract]   [Full Text] [Related]  

  • 28. Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells.
    Naito S; Shimizu S; Matsuu M; Nakashima M; Nakayama T; Yamashita S; Sekine I
    Biochem Biophys Res Commun; 2002 Feb; 291(1):130-8. PubMed ID: 11829472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the release of von Willebrand factor from endothelial cells after venous occlusion.
    Casonato A; Pontara E; Bertomoro A; Zucchetto A; Girolami A
    Thromb Haemost; 1998 Jun; 79(6):1216-7. PubMed ID: 9657453
    [No Abstract]   [Full Text] [Related]  

  • 30. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms.
    Colombatti A; Bonaldo P
    Blood; 1991 Jun; 77(11):2305-15. PubMed ID: 2039815
    [No Abstract]   [Full Text] [Related]  

  • 31. Nucleotide sequence of pre-pro-von Willebrand factor cDNA.
    Bonthron D; Orr EC; Mitsock LM; Ginsburg D; Handin RI; Orkin SH
    Nucleic Acids Res; 1986 Sep; 14(17):7125-7. PubMed ID: 3489923
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiation-induced von Willebrand factor release.
    Verheij M; Dewit L; van Mourik JA
    Blood; 1997 Sep; 90(5):2109-10. PubMed ID: 9292551
    [No Abstract]   [Full Text] [Related]  

  • 33. von Willebrand factor biosynthesis and processing.
    Mayadas TN; Wagner DD
    Ann N Y Acad Sci; 1991; 614():153-66. PubMed ID: 2024882
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic value of von Willebrand factor concentrations in pulmonary hypertension.
    Collados MT; Borbolla JR
    Chest; 2000 Oct; 118(4):1225-6. PubMed ID: 11035705
    [No Abstract]   [Full Text] [Related]  

  • 35. von Willebrand factor antigen and dental infections.
    Mattila K; Rasi V; Nieminen M; Valtonen V; Kesäniemi A; Syrjälä S; Jungell P; Huttunen JK
    Thromb Res; 1989 Oct; 56(2):325-9. PubMed ID: 2617473
    [No Abstract]   [Full Text] [Related]  

  • 36. von Willebrand factor, now cloned.
    Lynch DC; Zimmerman TS; Ruggeri ZM
    Br J Haematol; 1986 Sep; 64(1):15-20. PubMed ID: 3489483
    [No Abstract]   [Full Text] [Related]  

  • 37. Development and characterisation of a large diameter decellularised vascular allograft.
    Aldridge A; Desai A; Owston H; Jennings LM; Fisher J; Rooney P; Kearney JN; Ingham E; Wilshaw SP
    Cell Tissue Bank; 2018 Sep; 19(3):287-300. PubMed ID: 29188402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells.
    Addis R; Campesi I; Fois M; Capobianco G; Dessole S; Fenu G; Montella A; Cattaneo MG; Vicentini LM; Franconi F
    Biol Sex Differ; 2014; 5(1):18. PubMed ID: 25535548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Historical perspective and future directions in platelet research.
    Coller BS
    J Thromb Haemost; 2011 Jul; 9 Suppl 1(Suppl 1):374-95. PubMed ID: 21781274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience.
    Edel E; Al-Ali HK; Seeger S; Kauschat D; Matthes G
    Transfus Med Hemother; 2010 Feb; 37(1):13-19. PubMed ID: 20737012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.